Join Us at ADLM 2024

Are you attending ADLM 2024 in Chicago, IL?

Join us at booth 2232 to learn more about how BD Integrated Diagnostic Solutions can help to drive laboratory efficiencies and support clinical decisions through integrated automation and testing innovation to meet your evolving needs.

System and product demonstrations will include:

• Specimen Management Solutions, including BD MiniDraw™ Capillary Blood Collection System
• Molecular Solutions for Women’s Health and Cancer
• Molecular Solutions for Enterics
• Bloodstream Infection Solutions
• Identification and Antimicrobial Susceptibility Solutions
• Lab Automation Solutions

Please join us at these BD Sponsored presentations and events:

Preparing for the future of laboratory testing: a fireside chat and cocktail reception with BD

July 30th 3:30 p.m. in booth #2232

Renee Howell, PhD   VP, Medical Affairs, Specimen Management,  BD Life Sciences Panel moderator	Tim Skelton, MD, PhD, DABP Medical Director, Core Laboratory and Clinical Informatics, Lahey Hospital & Medical Center Medical Director, Laboratory and Pathology Informatics, Beth Israel Lahey Health Burlington, MA	Bridget C. Bagnato Worldwide President, Specimen Management BD Life Sciences	Stacy Melanson, MD, PhD Associate Professor of Pathology, Harvard Medical School Associate Clinical Director, Mass General Brigham Enterprise Laboratory Services Vice Chair, Clinical Laboratories, Brigham and Women’s Hospital Medical Director, Phlebotomy, Brigham and Women’s Hospital Boston, MA

Join us for a panel discussion among industry leaders and BD President of Specimen Management, Bridget Bagnato. Renee Howell, PhD MLS(ASCP), BD VP of Medical Affairs, Specimen Management will moderate. Our panelists will discuss how they are preparing for the future of laboratory testing and will take questions from the audience.

How novel capillary technologies can target unmet blood testing needs in traditional and emerging care sites

July 31st at 10:30 – 10:50 a.m. in Exhibit Hall Theater 2

	Dr. Michael Ries Medical Director Critical Care and eICU at Advocate Health Care

Although laboratory tests inform up to 70% of all clinical decisions and can aid clinicians in diagnosing, monitoring, and treating acute and chronic conditions every day, blood testing may be underutilized by patients in the United States. Traditional venous blood collection has been preferred for many decades. When this type of collection is not applicable for certain patients, other methods will need to be utilized such as capillary collection. In this session, you will hear Dr. Ries, Medical Director of Critical Care and eICU at AdvocateAurora, discuss a case study(s) about how difficult access to venipuncture can have an impact on patient care and clinical outcomes. You will also learn about a novel capillary blood collection device, the BD MiniDraw™ Capillary Blood Collection System, that is designed to address gaps in the current blood testing landscape.

Empowering laboratories efficiency: spotlight on molecular automation & HPV extended genotyping

July 31st at 2:45 – 3:45 p.m. in Exhibit Hall Theater 3

	Melissa Randolph Cytopathology Manager of Operations at Indiana University Health

Join us for an immersive symposium on the forefront of cervical cancer prevention and molecular diagnostics. This event will highlight cutting-edge advancements in integrated molecular automation and innovative assay design, with a specific focus on transforming screening practices through expanded extended genotyping result offering.

Discover how integrated molecular automation systems, such as the BD COR™ System, are revolutionizing laboratory efficiency and throughput, allowing for high-throughput processing of samples with minimal manual intervention. Pairing the capabilities of BD COR™ System with the BD Onclarity™ HPV Assay, the first FDA-approved HPV test with extended genotyping, designed to provide comprehensive risk assessment and personalized patient care.

Explore the impact of self-collection in healthcare settings on improving screening access and patient engagement, addressing barriers that hinder traditional cervical cancer screening. Gain insights into successful implementation strategies from global programs and understand how self-collection is reshaping cervical cancer screening paradigms.